Article
Amid Exkivity launch, Takeda beefs up in-house digital content team, AI to educate oncologists
Rating:
0.0
Views:
62
Likes:
1
Library:
1
With the launch of its new niche lung cancer drug Exkivity in September last year and a slew of precision cancer meds in the pipeline, Takeda Oncology is upping its digital content game in response | With the launch of its new niche lung cancer drug Exkivity in September and a slew of precision cancer meds in the pipeline, Takeda Oncology is upping its digital content game in response to the disruption in industry brought on by the pandemic.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value